Reuters logo
BRIEF-Sarepta Therapeutics announces proposed offering of $375 mln of convertible senior notes
November 7, 2017 / 9:48 PM / a month ago

BRIEF-Sarepta Therapeutics announces proposed offering of $375 mln of convertible senior notes

Nov 7 (Reuters) - Sarepta Therapeutics Inc

* Sarepta Therapeutics announces proposed offering of $375 million of convertible senior notes due 2024

* Sarepta Therapeutics Inc - ‍Chief Executive Officer indicates interest in purchasing $2 million of shares of Sarepta’s common stock​

* Sarepta - ‍intends to use a portion of net proceeds from offering to pay cost of certain capped call transactions​

* Sarepta - ‍purchase price/share of stock bought by ingram expected to equal closing price/share of co’s stock on date of pricing of offering​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below